The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma

Affiliations

• ¹ Department of Hematology, the First Hospital of Jilin University, Changchun, Jilin, China.
• ² Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin, China.
• ³ Department of Hematology and Oncology, Shanghai Jing'an District Zhabei Central Hospital, Shanghai, China.
• ⁴ Department of Hematology, Peking University First Hospital, Beijing, China.
• ⁵ Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, Shanxi, China.
• ⁶ Department of Hematology, the Affiliated Hospital of Hebei University, Baoding, Hebei, China.
• ⁷ Department of Radiology, the First Hospital of Jilin University, Changchun, Jilin, China.
• ⁸ Department Hematology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
• ⁹ Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin, China. daiyun@jlu.edu.cn.
• ¹⁰ Department of Hematology, the First Hospital of Jilin University, Changchun, Jilin, China. fengyanjin@jlu.edu.cn.